Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients
| Data(s) |
2011
|
|---|---|
| Resumo |
Since erythropoiesis-stimulating agents (ESAs) were licensed in 1993, more than 70 randomized controlled trials and more than 20 meta-analyses and systematic reviews on their effectiveness were conducted. Here, we present a systematic review on the meta-analyses of trials evaluating ESAs in cancer patients. |
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/7273/1/Tonia%20%20CancerTreatRes%202011.pdf Tonia, Thomy; Bohlius, Julia (2011). Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients. Cancer Treatment and Research, 157, pp. 217-238. New York, N.Y.: Springer Science+Business Media doi:10.7892/boris.7273 info:pmid:21052959 urn:issn:0927-3042 |
| Idioma(s) |
eng |
| Publicador |
Springer Science+Business Media |
| Relação |
http://boris.unibe.ch/7273/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Tonia, Thomy; Bohlius, Julia (2011). Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients. Cancer Treatment and Research, 157, pp. 217-238. New York, N.Y.: Springer Science+Business Media |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |
